Effects and Mechanisms of Resveratrol on the Amelioration of Oxidative Stress and Hepatic Steatosis in KKAy Mice

Overview

Journal Nutr Metab (Lond)

Publisher Biomed Central

Date 2014 Aug 21

PMID 25140191

Citations 30

Authors

Wei Zhu

Sifan Chen

Zilun Li

Xiaohong Zhao

Wenxue Li

Yanshuang Sun

Zili Zhang

Wenhua Ling

Xiang Feng

Affiliations

Soon will be listed here.

Abstract

Background: The exact mechanism of the protective role of Resveratrol (Res) in lipid metabolism and oxidative stress is not well elucidated. The present study aimed to investigate the potential benefits and possible mechanisms of Res on the amelioration of oxidative stress and hepatic steatosis in a KKAy mouse model.

Methods: A total of 30 KKAy male mice were randomly divided into three groups: a normal chow group, a low resveratrol group and a high resveratrol group. After a 12-wk study period, serum levels of TG, TC, LDL-C and HDL-C, the liver content of TG and TC, ROS, GSH, GPx, SOD and MDA levels were measured. Ectopic lipid deposition was observed in sectioned frozen liver tissues. The mRNA levels of ATGL and HSL in the liver tissues were determined via real-time PCR. Furthermore, the protein expression of p47phox, gp91phox, ATGL, HSL, Sirt1, AMPK and FOXO1 were analyzed using western blotting.

Results: Following Res supplementation, serum levels of TG and MDA were decreased, while the HDL-C and SOD levels were increased in KKAy mice. Furthermore, Res treatment increased GSH and GPx in liver tissues, while it decreased ROS. In addition, Res significantly reduced hepatic steatosis. After Res treatment, concentrations of p47phox (membrane) and gp91phox proteins were reduced, while p-HSL, HSL and ATGL protein expression levels were increased. Mechanistically, the levels of Sirt1, p-AMPK and p-FOXO1 expression in the liver tissues were up-regulated following supplementation with Res, and FOXO1 protein was released from the nucleus into the cytoplasm.

Conclusions: Res is able to attenuate hepatic steatosis and lipid metabolic disorder and enhance the antioxidant ability in KKAy mice, possibly by up-regulating Sirt1 expression and the phosphorylation of AMPK.

Citing Articles

Role of trans-resveratrol in ameliorating biochemical and molecular alterations in obese rats induced by a high fructose/fat diet.

Khamis M, Moselhy S, Rihan S Sci Rep. 2025; 15(1):7879.

PMID: 40050385 PMC: 11885455. DOI: 10.1038/s41598-025-91027-7.

Targeting AMPK related signaling pathways: A feasible approach for natural herbal medicines to intervene non-alcoholic fatty liver disease.

Cai Y, Fang L, Chen F, Zhong P, Zheng X, Xing H J Pharm Anal. 2025; 15(1):101052.

PMID: 40034684 PMC: 11873010. DOI: 10.1016/j.jpha.2024.101052.

Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research.

Sha X, Zou X, Liu S, Guan C, Shi W, Gao J Front Nutr. 2024; 11:1426780.

PMID: 39021599 PMC: 11253077. DOI: 10.3389/fnut.2024.1426780.

Overexpression of GPX2 gene regulates the development of porcine preadipocytes and skeletal muscle cells through MAPK signaling pathway.

Zhang C, Wang L, Qin L, Luo Y, Wen Z, Vignon A PLoS One. 2024; 19(5):e0298827.

PMID: 38722949 PMC: 11081289. DOI: 10.1371/journal.pone.0298827.

Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver.

Meng D, Zhang F, Yu W, Zhang X, Yin G, Liang P Diabetes Metab Syndr Obes. 2023; 16:4043-4064.

PMID: 38089432 PMC: 10715014. DOI: 10.2147/DMSO.S437865.

References

Beher D, Wu J, Cumine S, Kim K, Lu S, Atangan L . Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des. 2009; 74(6):619-24. DOI: 10.1111/j.1747-0285.2009.00901.x. View

Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X . SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 2007; 6(4):307-19. DOI: 10.1016/j.cmet.2007.08.014. View

Aronis A, Madar Z, Tirosh O . Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radic Biol Med. 2005; 38(9):1221-30. DOI: 10.1016/j.freeradbiomed.2005.01.015. View

Long Y, Zierath J . AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006; 116(7):1776-83. PMC: 1483147. DOI: 10.1172/JCI29044. View

Barthel A, Schmoll D, Unterman T . FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab. 2005; 16(4):183-9. DOI: 10.1016/j.tem.2005.03.010. View

Zhang X, Cao J, Jiang L, Zhong L . Suppressive effects of hydroxytyrosol on oxidative stress and nuclear Factor-kappaB activation in THP-1 cells. Biol Pharm Bull. 2009; 32(4):578-82. DOI: 10.1248/bpb.32.578. View

Hubbard B, Gomes A, Dai H, Li J, Case A, Considine T . Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science. 2013; 339(6124):1216-9. PMC: 3799917. DOI: 10.1126/science.1231097. View

Lan F, Cacicedo J, Ruderman N, Ido Y . SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem. 2008; 283(41):27628-27635. PMC: 2562073. DOI: 10.1074/jbc.M805711200. View

Dobrian A, Schriver S, Khraibi A, Prewitt R . Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension. 2003; 43(1):48-56. DOI: 10.1161/01.HYP.0000103629.01745.59. View

10.

Donnelly K, Smith C, Schwarzenberg S, Jessurun J, Boldt M, Parks E . Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005; 115(5):1343-51. PMC: 1087172. DOI: 10.1172/JCI23621. View

11.

Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K . In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol. 2002; 37(1):56-62. DOI: 10.1016/s0168-8278(02)00073-9. View

12.

Masubuchi Y, Sugiyama S, Horie T . Th1/Th2 cytokine balance as a determinant of acetaminophen-induced liver injury. Chem Biol Interact. 2008; 179(2-3):273-9. DOI: 10.1016/j.cbi.2008.10.028. View

13.

Shakibaei M, Harikumar K, Aggarwal B . Resveratrol addiction: to die or not to die. Mol Nutr Food Res. 2008; 53(1):115-28. DOI: 10.1002/mnfr.200800148. View

14.

Cakir I, Perello M, Lansari O, Messier N, Vaslet C, Nillni E . Hypothalamic Sirt1 regulates food intake in a rodent model system. PLoS One. 2009; 4(12):e8322. PMC: 2790615. DOI: 10.1371/journal.pone.0008322. View

15.

Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

16.

Yen G, Duh P, Lin C . Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic Res. 2003; 37(5):509-14. DOI: 10.1080/1071576031000083099. View

17.

Ruderman N, Prentki M . AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov. 2004; 3(4):340-51. DOI: 10.1038/nrd1344. View

18.

Saltiel A, Kahn C . Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001; 414(6865):799-806. DOI: 10.1038/414799a. View

19.

Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F . Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127(6):1109-22. DOI: 10.1016/j.cell.2006.11.013. View

20.

Thirunavukkarasu M, Penumathsa S, Koneru S, Juhasz B, Zhan L, Otani H . Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med. 2007; 43(5):720-9. PMC: 2586116. DOI: 10.1016/j.freeradbiomed.2007.05.004. View